Feature Channels:

Respiratory Diseases and Disorders

Add to Favorites Subscribe Share
fbshare-Respiratory Diseases and Disorders

Showing results

110 of 1588
Newswise: Racism a Factor in Asthma Control for Young African American Children
  • Embargo expired:
    17-Sep-2019 12:00 AM EDT

Article ID: 718889

Racism a Factor in Asthma Control for Young African American Children

American College of Allergy, Asthma and Immunology (ACAAI)

A new article in Annals of Allergy, Asthma and Immunology shows an association between African American parents/guardians who have experienced the chronic stress associated with exposure to racism and poor asthma control in their young children.

Released:
12-Sep-2019 10:05 AM EDT
dh_horz_blue_crop.png
  • Embargo expired:
    16-Sep-2019 11:00 AM EDT

Article ID: 718919

Flavoring Ingredient Exceeds Safety Levels in E-Cigarettes and Smokeless Tobacco

Duke Health

A potential carcinogen that has been banned as a food additive is present in concerningly high levels in electronic cigarette liquids and smokeless tobacco products, according to a new study from Duke Health.

Released:
12-Sep-2019 1:05 PM EDT
Newswise: $8M Grant Funds Cincinnati Children’s as Coordinating Center for Lung Mapping Program

Article ID: 718964

$8M Grant Funds Cincinnati Children’s as Coordinating Center for Lung Mapping Program

Cincinnati Children's Hospital Medical Center

Building upon the initial five-year plan, LungMAP 2 includes research on normal lung development in early adulthood and abnormal development in selected rare lung diseases.

Released:
13-Sep-2019 1:30 PM EDT
APS_Profile.jpg
  • Embargo expired:
    12-Sep-2019 8:15 PM EDT

Article ID: 718384

Calculating Biological Processes Improves Accuracy of Breath Tests

American Physiological Society (APS)

Breath-based tests are gaining in popularity as a non-invasive diagnostic tool. Research into improving the collection and analysis of these tests will be presented today at the American Physiological Society (APS) Interface of Mathematical Models and Experimental Biology conference.

Released:
5-Sep-2019 1:05 PM EDT
Newswise: Researchers Discover New Drug Target for the Fatal Lung Disease PAH

Article ID: 718918

Researchers Discover New Drug Target for the Fatal Lung Disease PAH

Cincinnati Children's Hospital Medical Center

Targeting the protein Eyes Absent 3 (EYA3) may help prevent vascular remodeling in pulmonary arterial hypertension (PAH), according to new study from Cincinnati Children's.

Released:
12-Sep-2019 2:05 PM EDT
UKLockup.png

Article ID: 718909

Markey Researchers Discover Role of Nuclear Glycogen in Non-small Cell Lung Cancers

University of Kentucky

Researchers at the University of Kentucky Markey Cancer Center have made a breakthrough discovery that solves a mystery long forgotten by science and have identified a potentially novel avenue in pre-clinical models to treat non-small cell lung cancers.

Released:
12-Sep-2019 12:05 PM EDT
Newswise: Texas Biomed Researchers Pinpoint Why HIV Patients Are More Likely to Develop Tuberculosis

Article ID: 718896

Texas Biomed Researchers Pinpoint Why HIV Patients Are More Likely to Develop Tuberculosis

Texas Biomedical Research Institute

Tuberculosis and HIV – two of the world’s deadliest infectious diseases – are far worse when they occur together. Now, Texas Biomedical Research Institute researchers have pinpointed an important mechanism at work in this troubling health problem. And, their discovery could lead to a new mode of treatment for people at risk.

Released:
12-Sep-2019 11:05 AM EDT
Newswise: Failed Cancer Drug Looks Promising For Scleroderma And Other Fibrotic Conditions

Article ID: 718812

Failed Cancer Drug Looks Promising For Scleroderma And Other Fibrotic Conditions

Johns Hopkins Medicine

Sixteen years ago, a research group at Mayo Medical School published results showing that a protein called TRAIL can kill cells that cause liver fibrosis but no one seemed to follow up on these findings. Now, researchers at Johns Hopkins Medicine have improved on this protein and shown that it selectively kills cells that cause the hardening of skin associated with scleroderma, effectively reversing the condition in mice genetically engineered to mimic the disease. A report on these results was published earlier this year in Nature Communications.

Released:
12-Sep-2019 9:00 AM EDT

Showing results

110 of 1588

Chat now!